<DOC>
	<DOC>NCT01400191</DOC>
	<brief_summary>The aim of the study is to evaluate the pharmacodynamic impact of metformin in healthy Caucasian volunteers with and without single polymorphisms M420del or R61C in OCT1, thus the study hypothesis is that metformin only affect the hepatic gluconeogenesis in healthy volunteers with functional OCT1-transporters.</brief_summary>
	<brief_title>The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Healthy volunteers Written consent Genotyped in OCT1 for (M420del and R61C) Daily medication Alcohol abuse Pregnancy Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Hypoglycemic Agents</keyword>
	<keyword>Diabetes Mellitus, Type 2</keyword>
	<keyword>Gluconeogenesis</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Pharmacogenetics</keyword>
</DOC>